中文 | English
Return
Total: 3164 , 1/317
Show Home Prev Next End page: GO
Author:(Hu LI-YANG)

1.Advances in anti-vasculogenic mimicry therapy

Dongxiao HU ; Li YANG

International Journal of Surgery 2011;38(4):267-270

2.Health Outcome Measurement in Pharmacoeconomic Evaluation

Li YANG ; Shanlian HU

China Pharmacy 1991;0(02):-

3.Development and Practice of Pharmacoeconomics in Aisa - Pacific Region

Li YANG ; Shanlian HU

China Pharmacy 1991;0(04):-

4.Configuring Anti-earthquake Medical Resource and Improving Medical Insurance

Junzhi HU ; Yang LI

Chinese Medical Equipment Journal 1993;0(06):-

5.Simulation study of influences of chain length on the shielding effect of PEGylated nanoparticles

Yang LI ; Ying HU

International Journal of Biomedical Engineering 2014;37(4):193-196,后插3

6.International Experience of Pharmacoeconomic Evaluation in Health Decsion-making

Li YANG ; Shanlian HU

China Pharmacy 1991;0(06):-

7.Cost Definition in Pharmacoeconomic Evaluation and Existing Controversy

Li YANG ; Shanlian HU

China Pharmacy 2001;0(11):-

8.Expression pattern of different serotypes of adeno-associated viral vectors in mouse retina.

Shuang HU ; Li Ping YANG

Journal of Peking University(Health Sciences) 2020;52(5):845-850

9.Improvement Strategies for Chinese Herbal Medicine Packaging

Haoxiong YANG ; Yang HU ; Li CUI

Chinese Journal of Information on Traditional Chinese Medicine 2016;23(5):13-15

10.Ischemic preconditioning protects against myocardial ischemia-reperfusion injury through inhibiting toll-like receptor 4/NF-kB signaling pathway in rats

Jing YANG ; Yuanjian LI ; Changping HU

Journal of Central South University(Medical Sciences) 2011;36(10):972-978

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3164 , 1/317 Show Home Prev Next End page: GO